Correlation Between Innovator IBD and 191216CP3
Specify exactly 2 symbols:
By analyzing existing cross correlation between Innovator IBD 50 and KO 4125 25 MAR 40, you can compare the effects of market volatilities on Innovator IBD and 191216CP3 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innovator IBD with a short position of 191216CP3. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innovator IBD and 191216CP3.
Diversification Opportunities for Innovator IBD and 191216CP3
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Innovator and 191216CP3 is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Innovator IBD 50 and KO 4125 25 MAR 40 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on KO 4125 25 and Innovator IBD is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innovator IBD 50 are associated (or correlated) with 191216CP3. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of KO 4125 25 has no effect on the direction of Innovator IBD i.e., Innovator IBD and 191216CP3 go up and down completely randomly.
Pair Corralation between Innovator IBD and 191216CP3
Given the investment horizon of 90 days Innovator IBD 50 is expected to under-perform the 191216CP3. In addition to that, Innovator IBD is 1.39 times more volatile than KO 4125 25 MAR 40. It trades about -0.03 of its total potential returns per unit of risk. KO 4125 25 MAR 40 is currently generating about 0.15 per unit of volatility. If you would invest 8,691 in KO 4125 25 MAR 40 on December 30, 2024 and sell it today you would earn a total of 567.00 from holding KO 4125 25 MAR 40 or generate 6.52% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 40.32% |
Values | Daily Returns |
Innovator IBD 50 vs. KO 4125 25 MAR 40
Performance |
Timeline |
Innovator IBD 50 |
KO 4125 25 |
Innovator IBD and 191216CP3 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Innovator IBD and 191216CP3
The main advantage of trading using opposite Innovator IBD and 191216CP3 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innovator IBD position performs unexpectedly, 191216CP3 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 191216CP3 will offset losses from the drop in 191216CP3's long position.Innovator IBD vs. Innovator ETFs Trust | Innovator IBD vs. iShares Expanded Tech Software | Innovator IBD vs. iShares MSCI USA | Innovator IBD vs. Renaissance IPO ETF |
191216CP3 vs. Monster Beverage Corp | 191216CP3 vs. Diageo PLC ADR | 191216CP3 vs. Turning Point Brands | 191216CP3 vs. British American Tobacco |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |